🚨New study of 197 cancer patients treated with Ivermectin (25 mg) + Mebendazole (250 mg): After 6 months: • 84.4% had clinical benefit • 48.4% had tumor reduction or no detectable disease • 86.9% completed treatment with mild side effects Dr. Peter McCullough explains.